Table 2.
Clinical and biochemical characteristics at continuous renal replacement therapy initiation; number, duration, and clotting rate.
| ID | Time-to-start (h) | Indication | UO (ml/Kg/h), FO (%) | sCr (umol/L) | BUN (mmol/L) | K (mmol/L) | CRRT sessions | |
|---|---|---|---|---|---|---|---|---|
| Number, mean duration (h) | Clotting rate | |||||||
| 1 | 17 | FO | 1.8, 24.1 | 92.8 | 3.2 | 5.9 | 10, 27.5 | 2/10 |
| 2 | 150 | FO | 1.1, 31.1 | 61.9 | 22.8 | 3.5 | 3, 21.1 | 3/3 |
| 5 | 217 | FO | 1.3, 120.7 | 35.4 | 6.0 | 3.8 | 5, 29.3 | 3/5 |
| 6 | 7 | Hyperazotemia | 0.1, 0.4 | 594.2 | 51.2 | 4.8 | 5, 38.4 | 1/5 |
| 7 | 395 | FO | 4.0, 200.0 | 77.8 | 37.3 | 6.6 | 4, 12.3 | 1/4 |
| 8 | 4 | Hyperazotemia | 0.0, 1.8 | 634.0 | 58.2 | 6.5 | 9, 20.1 | 8/9 |
| 9 | 41 | FO | 0.5, 27.4 | 114.9 | 29.3 | 4.7 | 4, 16.4 | 4/4 |
| 10 | 60 | FO | 0.2, 21.1 | 201.6 | 20.3 | 3.4 | 2, 21.5 | 2/2 |
| 11 | 74 | FO | 5.1, 12.4 | 62.8 | 13.0 | 3.5 | 1, 22.2 | 1/1 |
| 12 | 18 | FO | 0.5, 15.1 | 142.4 | 19.5 | 3.6 | 5, 49.7 | 4/5 |
| 13 | 27 | FO | 2.1, 10.4 | 114.9 | 21.7 | 4.3 | 7, 10.0 | 6/7 |
| 14 | 28 | FO | 1.5, 8.2 | 22.1 | 8.0 | 5.1 | 3, 48.9 | 0/3 |
| 15 | 168 | FO | 2.1, 18.5 | 82.2 | 22.5 | 4.6 | 6, 66.5 | 2/6 |
| 16 | 219 | Hyperkalemia | 0.3,−4.1 | 133.5 | 37.3 | 6.0 | 7, 74.9 | 0/7 |
| 18 | 40 | FO | 1.8, 10.8 | 79.6 | 7.3 | 3.4 | 4, 59.7 | 2/4 |
| 19 | 11 | Hyperazotemia | 0.4, 4.7 | 847.1 | 44.3 | 4.1 | 1, 9.8 | 0/1 |
| 20 | 22 | Hyperkalemia | 0.0, 2.8 | 132.6 | 6.0 | 5.9 | 1, 4.5 | 1/1 |
| 21 | 7 | Hyperazotemia | 0.1, 0.7 | 610.1 | 48.3 | 4.5 | 3, 68.8 | 0/3 |
| 22 | 188 | FO | 0.1, 8.9 | 70.7 | 6.7 | 3.3 | 1, 32.1 | 1/1 |
| 23 | 61 | Hyperazotemia | 0.8, 4.9 | 448.3 | 29.3 | 4.8 | 8, 49.5 | 7/8 |
| 25 | 29 | Shock in IHD | 1.9, 0.1 | IHD | 20.3 | 5.4 | 6, 31.0 | 3/6 |
| 26 | 38 | Hyperazotemia | 0.7,−0.2 | 154.7 | 44.8 | 4.4 | 4, 64.2 | 2/4 |
| 28 | 210 | FO | 2.7, 28.6 | 238.7 | 24.5 | 4.5 | 2, 79.8 | 0/2 |
Clotting rate represents the proportion of clotted sessions for each patient. A clotting rate > than 25% identifies patients at “high clotting rate.” BUN, blood urea nitrogen; FO, fluid overload; IHD, intermittent hemodialysis; K, potassium; sCr, serum creatinine; Time-to-start, time from admission to CRRT initiation; UO, urinary output.